CATAPRESSAN 0,15 mg/ml, solution injectable

Business Listing - September 04, 2021

CATAPRESSAN 0,15 mg/ml, solution injectable

CATAPRESSAN 0,15 mg/ml, solution injectable solution injectable intramusculaire;intraveineuse Autorisation active Procédure nationale Commercialisée 12/1/1986 GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE

Tags & Categories

intraveineuse active solution injectable autorisation procédure commercialisée nationale intramusculaire catapressan

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business